{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:29:32Z","timestamp":1760189372604},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T00:00:00Z","timestamp":1402531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.aprim.2014.04.013","type":"journal-article","created":{"date-parts":[[2014,7,14]],"date-time":"2014-07-14T17:45:36Z","timestamp":1405359936000},"page":"440-446","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hiperlipidemia familiar combinada: documento de consenso"],"prefix":"10.1016","volume":"46","author":[{"given":"Pedro","family":"Mata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Ru\u00edz-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose L.","family":"D\u00edaz-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noem\u00ed","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Gij\u00f3n-Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ceferino","family":"Mart\u00ednez-Faedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Mor\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezequiel","family":"Arranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Argueso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leopoldo","family":"Perez de Isla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2014.04.013_bib0005","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI107332","article-title":"Hyperlipidemia in coronary artery disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia","volume":"52","author":"Goldstein","year":"1973","journal-title":"J Clin Invest"},{"key":"10.1016\/j.aprim.2014.04.013_bib0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0021-9150(97)00134-2","article-title":"Phenotype expression in familial combined hyperlipidemia","volume":"133","author":"Porkka","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.aprim.2014.04.013_bib0015","first-page":"877","article-title":"Practical guidelines for familial combined hyperlipidemia diagnosis: An up-date","volume":"3","author":"Gaddi","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.aprim.2014.04.013_bib0020","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/01.CIR.0000081777.17879.85","article-title":"Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: A case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study","volume":"108","author":"Hopkins","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.aprim.2014.04.013_bib0025","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/eurheartj\/ehp051","article-title":"Familial-combined hyperlipidaemia in very young myocardial infarction survivors (<or =40years of age)","volume":"30","author":"Wiesbauer","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.aprim.2014.04.013_bib0030","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/CS20070101","article-title":"Five-year follow up of waist circumference, insulin and ALT levels in familial combined hyperlypidaemia","volume":"113","author":"Brouwers","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.aprim.2014.04.013_bib0035","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.metabol.2006.09.007","article-title":"Metabolic syndrome prevalence and characteristics in Greek adults with familial combined hyperlipidemia","volume":"56","author":"Skoumas","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.aprim.2014.04.013_bib0040","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE Next Steps Consortium. AGREE II: Advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.aprim.2014.04.013_bib0045","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 15. Going from evidence to recommendations: The significance and presentation of recommendations","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.aprim.2014.04.013_bib0050","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2012.15","article-title":"The genetics of familial combined hyperlipidaemia","volume":"8","author":"Brouwers","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.aprim.2014.04.013_bib0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2362.2002.00941.x","article-title":"A proposal to redefine familial combined hyperlipidaemia \u2014 Third workshop on FCH held in Barcelona from 3 to 5 May 2001, during the Scientific Sessions of the European Society for Clinical Investigation","volume":"32","author":"Sniderman","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.aprim.2014.04.013_bib0060","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/hq0202.104059","article-title":"Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families","volume":"22","author":"Veerkamp","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.aprim.2014.04.013_bib0065","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1161\/01.CIR.0000130646.93255.86","article-title":"Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study","volume":"109","author":"Veerkamp","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.aprim.2014.04.013_bib0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2011.06.028","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"217","author":"Catapano","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.aprim.2014.04.013_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2012.05.007","volume":"223","author":"Perk","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.aprim.2014.04.013_bib0080","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet","volume":"368","author":"Estruch","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aprim.2014.04.013_bib0085","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170.000 participants in 26 randomised trials","volume":"376","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2014.04.013_bib0090","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1161\/01.CIR.0000068312.21969.C8","article-title":"Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: A prospective, randomized, double-blind trial","volume":"107","author":"Ballantyne","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.aprim.2014.04.013_bib0095","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF03256580","volume":"9","author":"Ansquer","year":"2009","journal-title":"Am J Cardiovascu Drugs"},{"key":"10.1016\/j.aprim.2014.04.013_bib0100","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.medcli.2012.09.030","article-title":"Dyslipemia in diabetics treated with statins. Results of the dyslipidemia international study in Spain","volume":"141","author":"Mill\u00e1n","year":"2013","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.aprim.2014.04.013_bib0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1253\/circj.CJ-12-0320","article-title":"Impact of cardiometabolic risk factors on major cardiovascular events in patients with familial combined hyperlipidemia","volume":"77","author":"Skoumas","year":"2013","journal-title":"Circ J"},{"issue":"Suppl 1","key":"10.1016\/j.aprim.2014.04.013_bib0110","first-page":"S4","article-title":"Executive summary: Standards of medical care in, diabetes \u2014 2013","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.aprim.2014.04.013_bib0115","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.aprim.2014.04.013_bib0120","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s00125-009-1470-0","article-title":"Intensive glucose control and macrovascular outcomes in type 2 diabetes","volume":"52","author":"Turnbull","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.aprim.2014.04.013_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M13-1725","article-title":"Prevention of diabetes with Mediterranean diets: A subgroup analysis of a randomized trial","volume":"160","author":"Salas-Salvad\u00f3","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.aprim.2014.04.013_bib0130","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2014.04.013_bib0135","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/jama.2010.405","article-title":"Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type2 diabetes","volume":"303","author":"Phung","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.aprim.2014.04.013_bib0140","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/dme.12232","article-title":"Sulphonylureas and risk of cardiovascular disease: Systematic review and meta-analysis","volume":"30","author":"Phung","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/j.aprim.2014.04.013_bib0145","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aprim.2014.04.013_bib0150","doi-asserted-by":"crossref","first-page":"e1369","DOI":"10.1136\/bmj.e1369","article-title":"Dipeptidyl peptidase-4 inhibitors for treatment of type2 diabetes mellitus in the clinical setting: Systematic review and meta-analysis","volume":"344","author":"Karagiannis","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.aprim.2014.04.013_bib0155","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology(ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.aprim.2014.04.013_bib0160","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1157\/13124015","article-title":"Evaluaci\u00f3n y tratamiento de la hipertensi\u00f3n arterial en Espa\u00f1a. Documento de consenso","volume":"131","author":"De la Sierra","year":"2008","journal-title":"Med Clin"}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656714002030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656714002030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T16:03:04Z","timestamp":1565625784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656714002030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0212656714002030"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2014.04.013","relation":{},"ISSN":["0212-6567"],"issn-type":[{"type":"print","value":"0212-6567"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hiperlipidemia familiar combinada: documento de consenso","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2014.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}